Dual Antiplatelet Therapy in Patients With Prior Myocardial Infarction: The Twilight of Prolonged DAPT Duration?

JACC Cardiovasc Interv. 2022 Feb 14;15(3):294-296. doi: 10.1016/j.jcin.2021.11.034. Epub 2022 Jan 12.

Authors

Eli I Lev¹, Eyal Ben-Assa²

Affiliations

¹ Cardiology Department, Assuta Ashdod Medical Center and the Ben-Gurion University of the Negev, Ashdod, Israel. Electronic address: elil@assuta.co.il.
² Cardiology Department, Assuta Ashdod Medical Center and the Ben-Gurion University of the Negev, Ashdod, Israel.

PMID: 35033469
DOI: 10.1016/j.jcin.2021.11.034

No abstract available

Keywords: P2Y(12) inhibitor monotherapy; acute coronary syndrome; antiplatelet therapy; high bleeding risk; myocardial infarction.

Publication types

Editorial
Comment

MeSH terms

Dual Anti-Platelet Therapy
Humans
Myocardial Infarction* / diagnostic imaging
Myocardial Infarction* / drug therapy
Platelet Aggregation Inhibitors* / adverse effects
Treatment Outcome

Substances

Platelet Aggregation Inhibitors